Pathway analysis of single-nucleotide polymorphisms potentially associated with glioblastoma multiforme susceptibility using random forests

Cancer Epidemiology Biomarkers and Prevention

Volumn 17, Issue 6, 2008, Pages 1368-1373

  Chang, Jeffrey S ^a   Yeh, Ru Fang ^a   Wiencke, John K ^a   Wiemels, Joseph L ^a   Smirnov, Ivan ^a   Pico, Alexander R ^b   Tihan, Tarik ^a   Patoka, Joe ^a   Miike, Rei ^a   Sison, Jennette D ^a   Rice, Terri ^a   Wrensch, Margaret R ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CONTROLLED STUDY; DNA REPAIR; FEMALE; GENE INTERACTION; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC SUSCEPTIBILITY; GENOTYPE; GLIOBLASTOMA; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RANDOM FOREST; SINGLE NUCLEOTIDE POLYMORPHISM;

BRAIN NEOPLASMS; CASE-CONTROL STUDIES; CHROMOSOMAL PROTEINS, NON-HISTONE; DNA-BINDING PROTEINS; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; GENE EXPRESSION PROFILING; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; GLIOBLASTOMA; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; PHENOTYPE; PILOT PROJECTS; POLYMORPHISM, SINGLE NUCLEOTIDE; RISK;

EID: 53349100175     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: 10.1158/1055-9965.EPI-07-2830     Document Type: Article

References (33)

1. Breiman L. Random forests. Machine Learning 2001;45:5-32.
2. Breiman L, Cutler A. 2007. Available from: http://www.math.usu.edu/ ~adele/forests/.
3. Lunetta KL, Hayward LB, Segal J, Van Eerdewegh P. Screening largescale association study data: exploiting interactions using random forests. BMC Genet 2004;5:32.
4. Diaz-Uriarte R, Alvarez de Andres S. Gene selection and classification of microarray data using random forest. BMC Bioinformatics 2006;7:3.
5. Pang H, Lin A, Holford M, et al. Pathway analysis using random forests classification and regression. Bioinformatics 2006;22:2028-36.
6. Wiemels JL, Wiencke JK, Kelsey KT, et al. Allergy-related polymorphisms influence glioma status and serum IgE levels. Cancer Epidemiol Biomarkers Prev 2007;16:1229-35.
7. Wrensch M, McMillan A, Wiencke J, et al. Nonsynonymous coding single-nucleotide polymorphisms spanning the genome in relation to glioblastoma survival and age at diagnosis. Clin Cancer Res 2007;13:197-205.
8. Hardenbol P, Yu F, Belmont J, et al. Highly multiplexed molecular inversion probe genotyping: over 10,000 targeted SNPs genotyped in a single tube assay. Genome Res 2005;15:269-75.
9. Nebert DW, Dalton TP. The role of cytochrome P450 enzymes in endogenous signalling pathways and environmental carcinogenesis. Nat Rev Cancer 2006;6:947-60.
10. McIlwain CC, Townsend DM, Tew KD. Glutathione S-transferase polymorphisms: cancer incidence and therapy. Oncogene 2006;25:1639-48.
11. Wood RD, Mitchell M, Lindahl T. Human DNA repair genes, 2005. Mutat Res 2005;577:275-83.
12. 2/M checkpoint on genomic instability and cancer induction. Nat Rev Cancer 2007;7:861-9.
13. Jana S, Paliwal J. Apoptosis: potential therapeutic targets for new drug discovery. Curr Med Chem 2007;14:2369-79.
14. Hood JD, Cheresh DA. Role of integrins in cell invasion and migration. Nat Rev Cancer 2002;2:91-100.
15. Witz IP. The selectin-selectin ligand axis in tumor progression. Cancer Metastasis Rev 2008;27:19-30.
16. 2+ transport. Nat Rev Cancer 2007;7:519-30.
17. Wrensch M, Fisher JL, Schwartzbaum JA, Bondy M, Berger M, Aldape KD. The molecular epidemiology of gliomas in adults. Neurosurg Focus 2005;19:E5.
18. Golestaneh N, Mishra B. TGF-β, neuronal stem cells and glioblastoma. Oncogene 2005;24:5722-30.
19. Suzuki T, Maruno M, Wada K, et al. Genetic analysis of human glioblastomas using a genomic microarray system. Brain Tumor Pathol 2004;21:27-34.
20. Kanehisa M, Goto S, Hattori M, et al. From genomics to chemical genomics: new developments in KEGG. Nucleic Acids Res 2006;34:D354-7.
21. Biocarta Pathway Collections. Available from: http://www.biocarta.com/ genes/allPathways.asp.
22. Dahlquist KD, Salomonis N, Vranizan K, Lawlor SC, Conklin BR. GenMAPP, a new tool for viewing and analyzing microarray data on biological pathways. Nat Genet 2002;31:19-20.
23. Pico A, Smirnov I, Chang JS, et al. SNPLogic: an interactive web resource for the pathway-based selection and prioritization of SNPs for genotyping studies. American Association for Cancer Research, "Approaches to Complex Pathways in Molecular Epidemiology." Santa Ana Pueblo, New Mexico, May 30-June 2, 2007.
24. Cutler A, Stevens JR. Random forests for microarrays. Methods Enzymol 2006;411:422-32.
25. Efron B, Tibshirani R. Improvements on cross-validation: the .632+ bootstrap method. J Am Stat Assoc 1997;92:548-60.
26. Wrensch M, Kelsey KT, Liu M, et al. Glutathione-S-transferase variants and adult glioma. Cancer Epidemiol Biomarkers Prev 2004;13:461-7.
27. Lee KM, Nizza S, Hayes T, et al. Brc1-mediated rescue of Smc5/6 deficiency: requirement for multiple nucleases and a novel Rad18 function. Genetics 2007;175:1585-95.
28. Tran PT, Erdeniz N, Symington LS, Liskay RM. EXO1-A multi-tasking eukaryotic nuclease. DNA Repair (Amst) 2004;3:1549-59.
29. Osman F, Whitby MC. Exploring the roles of Mus81-1/Mms4at perturbed replication forks. DNA Repair (Amst) 2007;6:1004-17.
30. Williamson DW, Pico AR, Zambon AC, Conklin BR, Mahley RW. Delta-MATCH: predicting which single nucleotide polymorphisms may create allele-specific transcription factor binding sites (in progress).
31. Available from: http://genome.ucsc.edu/.
32. Bethke L, Webb E, Murray A, et al. Comprehensive analysis of the role of DNA repair gene polymorphisms on risk of glioma. Hum Mol Genet 2008;17:800-5.
33. Wacholder S, Rothman N, Caporaso N. Population stratification in epidemiologic studies of common genetic variants and cancer: quantification of bias. J Natl Cancer Inst 2000;92:1151-8.